Charlton B, Lafferty K J
John Curtin School of Medical Research, Australian National University, Canberra.
Curr Opin Immunol. 1995 Dec;7(6):793-8. doi: 10.1016/0952-7915(95)80050-6.
The study of autoimmune disease in the context of T-helper type 1 (Th1) and T-helper type 2 (Th2) CD4+ T-cell responses demonstrates that the relative contribution of either T-cell type to the development of a particular autoimmune response can influence whether or not this response leads to clinical disease. Moreover, this influence can be quite different depending on whether the particular disease process is cell mediated or antibody mediated. Recent studies have demonstrated that the development of Th1 and Th2 responses may be significantly influenced by the costimulatory molecules recognized by responding CD4 T cells, and by other undefined factors in the genetic background. It has also been demonstrated that autoreactive Th2 CD4+ cells can regulate the activity of disease-causing Th1 CD4+ T cells in vivo. Control of autoimmune disease may thus be achieved by procedures that regulate the relative contribution of Th1/Th2 CD4 T cells to an autoimmune response.
在1型辅助性T细胞(Th1)和2型辅助性T细胞(Th2)CD4 + T细胞反应的背景下对自身免疫性疾病的研究表明,这两种T细胞类型中任何一种对特定自身免疫反应发展的相对贡献,都可能影响该反应是否会导致临床疾病。此外,根据特定疾病过程是细胞介导还是抗体介导,这种影响可能会有很大差异。最近的研究表明,Th1和Th2反应的发展可能会受到反应性CD4 T细胞识别的共刺激分子以及遗传背景中其他未明确因素的显著影响。还证明了自身反应性Th2 CD4 +细胞在体内可以调节致病性Th1 CD4 + T细胞的活性。因此,通过调节Th1/Th2 CD4 T细胞对自身免疫反应的相对贡献的程序,可能实现对自身免疫性疾病的控制。